BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27993106)

  • 1. Fabrication, Characterization, In vitro Evaluation of Solid Lipid Nanoemulsion of Flunarizine dihydrochloride for Nasal Delivery.
    Newton MJ; Harjot K
    Antiinflamm Antiallergy Agents Med Chem; 2017; 15(3):204-220. PubMed ID: 27993106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoemulsion for Migraine Prophylaxis Nasal Drug Delivery: Preparation, Characterization and in vitro Evaluation.
    Harjot K; A M John N; Reeta
    Pharm Nanotechnol; 2016; 4(3):229-241. PubMed ID: 29052501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir Solid Lipid Nanoparticles for Skin Drug Delivery: Fabrication, Characterization and In vitro Study.
    Bhupinder K; Newton MJ
    Recent Pat Drug Deliv Formul; 2017; 11(2):132-146. PubMed ID: 28124592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis.
    Mohamad SA; Safwat MA; Elrehany M; Maher SA; Badawi AM; Mansour HF
    Drug Deliv; 2021 Dec; 28(1):229-239. PubMed ID: 33501873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of oral nanoemulsion drug delivery system of mebudipine.
    Khani S; Keyhanfar F; Amani A
    Drug Deliv; 2016 Jul; 23(6):2035-43. PubMed ID: 26406153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
    Wang YJ; Wang J; Zhang HY; He HB; Tang X
    J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
    Kumar J; Newton AMJ
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
    Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
    Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation.
    Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S
    Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NANOEMULSION WITH CLOTRIMAZOLE - DESIGN AND OPTIMALIZATION OF MEAN DROPLET SIZE USING MICROFLUIDIZATION TECHNIQUE.
    Sosnowska K; Szymanska E; Winnicka K
    Acta Pol Pharm; 2017 Mar; 74(2):519-526. PubMed ID: 29624257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency.
    Boche M; Pokharkar V
    AAPS PharmSciTech; 2017 Apr; 18(3):686-696. PubMed ID: 27207184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation.
    Nesamony J; Shah IS; Kalra A; Jung R
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1253-63. PubMed ID: 23837519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Pingkai O
    Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
    Rajpoot P; Bali V; Pathak K
    Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Deliv; 2015; 22(4):552-61. PubMed ID: 24512268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criterion for excipients screening in the development of nanoemulsion formulation of three anti-inflammatory drugs.
    Shakeel F
    Pharm Dev Technol; 2010; 15(2):131-8. PubMed ID: 19911951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies.
    Parikh RH; Patel RJ
    Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A redispersible dry emulsion system with simvastatin prepared via fluid bed layering as a means of dissolution enhancement of a lipophilic drug.
    Pohlen M; Pirker L; Luštrik M; Dreu R
    Int J Pharm; 2018 Oct; 549(1-2):325-334. PubMed ID: 30075251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonic/sonochemical synthesis and evaluation of nanostructured oil in water emulsions for topical delivery of protein drugs.
    Mohamadi Saani S; Abdolalizadeh J; Zeinali Heris S
    Ultrason Sonochem; 2019 Jul; 55():86-95. PubMed ID: 31084795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.